PMIS2
Proteasome Maturation Inhibitor Subunit 2
Gene Information Card
| Symbol | PMIS2 |
|---|---|
| Full Name | Proteasome Maturation Inhibitor Subunit 2 |
| Gene Type | protein-coding |
| Chromosomal Location | 1p36.22 |
| NCBI Gene ID | 100130449 ncbi.nlm.nih.gov/gene/100130449 |
| Ensembl ID | ENSG00000204310 |
| UniProt ID | Q5T8P6 |
| OMIM ID | 618394 |
| HGNC ID | 44038 |
| Aliases | MIR155HG, MIR155, BIC |
Description
PMIS2 (Proteasome Maturation Inhibitor Subunit 2) is a protein-coding gene located on chromosome 1p36.22. It encodes a subunit of the proteasome maturation inhibitor complex, which negatively regulates proteasome assembly and activity. The gene is also known as MIR155HG, as it hosts the microRNA MIR155 within its intron. PMIS2 is involved in immune response, hematopoiesis, and cancer biology.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Diffuse large B-cell lymphoma | Overexpression of MIR155 (hosted by PMIS2) promotes B-cell proliferation and survival | PMID: 16959974 |
| Breast cancer | PMIS2/MIR155 upregulation correlates with poor prognosis and metastasis | PMID: 22955915 |
| Hepatocellular carcinoma | MIR155 from PMIS2 locus enhances tumor growth via suppression of SOCS1 | PMID: 23966166 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Spleen | 12.5 | Medium |
| Lymph node | 10.2 | Medium |
| Bone marrow | 8.9 | Medium |
| Whole blood | 6.1 | Low |
| Liver | 3.4 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| K-562 | 15.3 | Leukemia cell line |
| Raji | 22.1 | Burkitt lymphoma cell line |
| HepG2 | 7.8 | Hepatocellular carcinoma cell line |
| MCF7 | 9.4 | Breast cancer cell line |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1A>G | SNV | <0.01% | Non-coding upstream variant |
| g.197G>A | SNV | 0.02% | Intronic variant near MIR155 |
Mutation functional classification
Loss of Function (LOF)
No confirmed loss-of-function mutations reported in PMIS2.
Gain of Function (GOF)
Overexpression of MIR155 (hosted by PMIS2) is associated with gain-of-function in lymphoma and solid tumors.
Dominant Negative (DN)
No dominant-negative mutations described.
View complete mutation data:
Gene Ontology (GO)
| • negative regulation of proteasome assembly | • protein binding |
| • cytoplasm |
Pathways
• Proteasome maturation
• MicroRNA biogenesis
• NF-kappaB signaling
Protein Summary
PMIS2 encodes a 15 kDa protein that inhibits proteasome maturation by binding to the proteasome precursor complexes. It is primarily expressed in lymphoid tissues and blood cells. The protein is localized in the cytoplasm and plays a role in regulating proteasome activity, thereby influencing protein homeostasis and immune cell function.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PMIS2 Knockout HeLa Cell Line | EDJ-KQ45247 | Human | 111216276 | Details Get a Quote |
| PMIS2 Knockout HCT 116 Cell Line | EDJ-KQ45246 | Human | 111216276 | Details Get a Quote |
| PMIS2 Knockout A-549 Cell Line | EDJ-KQ45245 | Human | 111216276 | Details Get a Quote |
| PMIS2 Knockout HEK293 Cell Line | EDJ-KQ14814 | Human | 111216276 | Details Get a Quote |